Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | LCK | P06239 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.30 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4447706 | 0.78 | TSHR (0.35) | TSHRALDH1A1CA2MAPK1CYP2D6 | |
| SCHEMBL10438608 | 0.78 | CYP2C9 (0.35) | TSHRALDH1A1CA2MAPK1CYP2D6 | |
| SCHEMBL25273935 | 0.78 | LCK (0.31) | ALDH1A1LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL10616009 | 0.76 | TSHR (0.33) | TSHRALDH1A1CA2MAPK1CYP2D6 | |
| SCHEMBL2703456 | 0.74 | LMNA (0.33) | TSHRALDH1A1CA2MAPK1CYP2D6 | |
| SCHEMBL5388712 | 0.72 | — | — | |
| SCHEMBL3465484 | 0.71 | LCK (0.30) | TSHRALDH1A1LCKPPARDZDHHC20 | |
| SCHEMBL21585899 | 0.71 | DPP4 (0.30) | LCKPPARDZDHHC20ZDHHC2 | |
| SCHEMBL11680928 | 0.70 | ALDH1A1 (0.38) | TSHRALDH1A1CYP2C19 | |
| SCHEMBL18112453 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107056834-B | A kind of synthetic method of artificial cell membrane's principal component 2- methylacryoyloxyethyl Phosphorylcholine | 苏州怡彼得生物技术有限公司 | 2019-02-15 | — | — | CN | claimed |
| CN-107056834-A | A kind of synthetic method of the methylacryoyloxyethyl Phosphorylcholine of artificial cell membrane's principal component 2 | 苏州怡彼得生物技术有限公司 | 2017-08-18 | — | — | CN | claimed |
| CN-109666100-A | A kind of synthetic method of artificial cell membrane material polyquaternium -51 | 苏州怡彼得生物技术有限公司 | 2019-04-23 | — | — | CN | disclosed |
| CN-107056834-B | A kind of synthetic method of artificial cell membrane's principal component 2- methylacryoyloxyethyl Phosphorylcholine | 苏州怡彼得生物技术有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-107056834-B | A kind of synthetic method of artificial cell membrane's principal component 2- methylacryoyloxyethyl Phosphorylcholine | 苏州怡彼得生物技术有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-108250058-A | PPAR agonists and their use in the treatment of Alzheimer's disease and other diseases | 上海怡立舍生物技术有限公司 | 2018-07-06 | — | — | CN | disclosed |
| CN-107056834-A | A kind of synthetic method of the methylacryoyloxyethyl Phosphorylcholine of artificial cell membrane's principal component 2 | 苏州怡彼得生物技术有限公司 | 2017-08-18 | — | — | CN | disclosed |